BioSig Technologies

BioSig Technologies

BioSig Technologies was originally a medical device company before a strategic repositioning toward digital-asset infrastructure. The firm now operates primarily through Streamex Corp., its subsidiary focused on tokenized securities. The pivot is public: its website positions the company under the Streamex brand and describes the launch of a secondary trading venue for compliant digital assets. The firm's strategy centers on decentralized secondary liquidity. The announced infrastructure, built with partner Orca, targets 24/7 trading of tokenized securities — a shift from traditional exchange hours and settlement cycles. The inaugural asset on the platform is GLDY, a gold-backed token. This signals a deployment focus on hard-asset tokenization within regulated frameworks, bypassing the more speculative corners of crypto. The partnership model suggests a build-and-license approach rather than an asset-management fee structure. No additional portfolio holdings or fund vehicles are publicly disclosed. As of mid-2026, team size and total deployment remain undisclosed. The firm lists its headquarters in Westport, Connecticut, with no additional offices confirmed. BioSig's pivot to Streamex represents a full corporate transformation rather than an incremental product launch — the investor relations page and homepage both identify the company as Streamex Corp., with BioSig as the legacy shell. No philanthropic vehicles or family-office relationships are known. BioSig's architecture is unusual: a publicly traded entity repurposed as an operating company in a novel regulatory gray zone. Most tokenization infrastructure is built within private startups or consortiums of banks. A publicly listed US company launching a decentralized secondary venue creates a distinct governance and disclosure profile — shareholders effectively hold an interest in market infrastructure for assets that push the boundary of SEC jurisdiction. This structure introduces capital-markets accountability into a space dominated by opaque private ventures.